Abstract
The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
Original language | English |
---|---|
Patent number | WO2013030588 |
IPC | C12Q 1/ 68 A I |
Priority date | 31/08/11 |
Publication status | Published - 7 Mar 2013 |